KalVista: SilverArc reports 2.88M shares (5.6%)

KalVista Pharmaceuticals Inc is reported as having 2,876,407 shares of Class A Common Stock beneficially owned by SilverArc Capital Management, LLC and Devesh Gandhi, representing 5.6% of the class as of 03/31/2026.

Rhea-AI Filing Summary

KalVista Pharmaceuticals Inc is reported as having 2,876,407 shares of Class A Common Stock beneficially owned by SilverArc Capital Management, LLC and Devesh Gandhi, representing 5.6% of the class as of 03/31/2026.

The filing states SilverArc acts as investment adviser to multiple funds that together account for the disclosed position, with specific allocations to named funds listed in the report.

Insights

Governance Analyst

Reporting shows a passive >5% stake held through an adviser structure.

The Schedule 13G identifies SilverArc Capital Management, LLC and Devesh Gandhi as reporting persons beneficially owning 2,876,407 shares (5.6%) as of 03/31/2026. The filing attributes holdings to multiple funds for which SilverArc is adviser.

Ownership is described as shared voting and dispositive power of 2,876,407 shares; the report lists per-fund breakdowns that may be relevant to understanding which client vehicles hold the exposure.

Key Figures

Beneficial ownership: 2,876,407 shares Percent of class: 5.6% SilverArc Capital Alpha Fund I: 64,386 shares +4 more

7 metrics

Beneficial ownership 2,876,407 shares Class A Common Stock as of 03/31/2026

Percent of class 5.6% Percent of Class A Common Stock

SilverArc Capital Alpha Fund I 64,386 shares portion of the 2,876,407 shares

SilverArc Capital Alpha Fund II 1,622,392 shares portion of the 2,876,407 shares

Squarepoint Diversified Partners Fund 605,017 shares portion of the 2,876,407 shares

Atom Master Fund L.P. 357,660 shares portion of the 2,876,407 shares

Map 243 Segregated Portfolio 226,952 shares portion of the 2,876,407 shares

Key Terms

beneficially owned, shared dispositive power, Schedule 13G

3 terms

beneficially owned regulatory

"deemed to be the beneficial owner of 2,876,407 shares"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

shared dispositive power regulatory

"Shared Dispositive Power 2,876,407.00"

Schedule 13G regulatory

"Item 1. Name of issuer: KalVista Pharmaceuticals Inc"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does SilverArc report in KalVista (KALV)?

SilverArc and Devesh Gandhi report beneficial ownership of 2,876,407 shares, representing 5.6% of Class A Common Stock as of 03/31/2026. The position is held through multiple client funds for which SilverArc is adviser.

Who is listed as the reporting person on the KALV filing?

The filing lists SilverArc Capital Management, LLC and Devesh Gandhi as the Reporting Persons. Gandhi is identified as Sole Member of SilverArc and signed the Schedule 13G dated 05/13/2026.

How is the 2,876,407-share position allocated across funds?

The filing breaks the position into named client vehicles: 64,386 (Alpha Fund I), 1,622,392 (Alpha Fund II), 605,017, 357,660, and 226,952 shares for other listed funds, summing to the reported 2,876,407 shares.

Does the filing show sole voting or dispositive power for KALV shares?

No. The Schedule 13G reports 0 shares with sole voting or dispositive power and 2,876,407 shares with shared voting and shared dispositive power, per the Ownership table.

Is this a passive or active disclosure under Schedule 13G for KALV?

The report is a Schedule 13G filing by an investment adviser describing beneficial ownership on behalf of clients. It presents an advisory/beneficial ownership relationship rather than an active acquisition narrative.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/13/2026 - 04:40 PM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

KalVista Pharmaceuticals Inc

(Name of Issuer)

Class A Common Stock

(Title of Class of Securities)

483497103

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 483497103

1

Names of Reporting Persons

SilverArc Capital Management, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 2,876,407.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 2,876,407.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,876,407.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.6 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

CUSIP Number(s): 483497103

1

Names of Reporting Persons

Devesh Gandhi

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 2,876,407.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 2,876,407.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,876,407.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.6 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: KalVista Pharmaceuticals Inc
(b)	Address of issuer's principal executive offices: 200 Crossing Boulevard Framingham, MA 01702
Item 2.
(a)	Name of person filing: SilverArc Capital Management, LLC ("SilverArc") and Devesh Gandhi ("Gandhi" and together with SilverArc, the "Reporting Persons")
(b)	Address or principal business office or, if none, residence: 20 Park Plaza, Suite 620 Boston, MA 02116
(c)	Citizenship: SilverArc is a Delaware limited liability company. Gandhi is a citizen of the United States.
(d)	Title of class of securities: Class A Common Stock
(e)	CUSIP Number(s): 483497103
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 2876407
(b)	Percent of class: 5.6 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 2876407
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 2876407
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. As of the date of this Report, SilverArc Capital Management, LLC ("SilverArc"), an investment adviser registered under Section 203 of the Investment Advisers Act of 1940, is deemed to be the beneficial owner of 2,876,407 shares, or 5.62% of the Common Stock believed to be outstanding, as a result of acting as investment adviser to various clients. Gandhi is the Sole Member of SilverArc and as such is deemed to be the beneficial owner of 2,876,407 shares, or 5.62% of the Common Stock believed to be outstanding. SilverArc Capital Alpha Fund I, L.P., a Delaware limited partnership for which SilverArc acts as an investment adviser, may be deemed to beneficially own 64,386 of these 2,876,407 shares, which equates to 0.13% of the Common Stock believed to be outstanding. SilverArc Capital Alpha Fund II, L.P., a Delaware limited partnership for which SilverArc acts as an investment adviser, may be deemed to beneficially own 1,622,392 of these 2,876,407 shares, which equates to 3.17% of the Common Stock believed to be outstanding. Squarepoint Diversified Partners Fund Limited, a Cayman Island exempted company for which SilverArc acts as investment adviser, may be deemed to beneficially own 605,017 of these 2,876,407 shares, which equates to 1.18% of the Common Stock believed to be outstanding. Atom Master Fund L.P., a Cayman Islands exempted limited partnership for which SilverArc acts as investment adviser, may be deemed to beneficially own 357,660 of these 2,876,407 shares, which equates to 0.70% of the Common Stock believed to be outstanding. Map 243 Segregated Portfolio, a Cayman Islands segregated portfolio company for which SilverArc acts as investment adviser, may be deemed to beneficially own 226,952 shares of these 2,876,407 shares, which equates to 0.44% of the Common Stock believed to be outstanding.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

SilverArc Capital Management, LLC

Signature:	Devesh S. Gandhi
Name/Title:	Sole Member of SilverArc Capital Management, LLC
Date:	05/13/2026

Devesh Gandhi

Signature:	Devesh S. Gandhi
Name/Title:	Sole Member of SilverArc Capital Management, LLC
Date:	05/13/2026